Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 539

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 539
---
 the Combination Period. On December 21, 2023, the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company has extended the Combination Period from December 22, 2023 to March 22, 2024. In connection with the extension, 140,663shares of the Company’s common stock were redeemed, with 6,027,219shares of Common Stock remaining outstanding after the Redemption; 833,469shares of Common Stock remaining outstanding after the Redemption are shares issued in connection with our initial public offering. In January 2024, $ 1,565,078was paid from the Trust Account to redeeming stockholders in connection with the extension. As a result, the Company has recorded a liability of $ 1,565,078as common stock to be redeemed and reduced common stock subject to possible redemption as of December 31, 2023 on the balance sheet. All of the Public Shares, or shares of our common stock sold as part of the IPO, contain a redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there is a stockholder vote or tender offer in connection with our initial business combination and in connection with certain amendments to our amended and restated certificate of incorporation. In accordance with SEC and its guidance on redeemable equity instruments, which has been codified in ASC 480 -10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares were issued with other freestanding instruments (i.e., public warrants), the initial carrying value of common stock classified as temporary equity was the allocated proceeds determined in accordance with ASC 470 -20. The common stock is subject to ASC 480 -10-S99. If it is probable that the equity instrument will become redeemable, we have the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each F-34 NORTHVIEW ACQUISITION CORPORATION Notes to Consolidated Financial Statements Note 1 — Description of Organization and Business Operations (cont.) reporting period. We have elected to recognize the